Modern Chinese Medicine Group Co., Ltd. (HKG:1643)
Hong Kong · Delayed Price · Currency is HKD 0.7500
+0.1000 (15.38%)
Jul 17, 2025, 4:08 PM HKT
HKG:1643 Revenue
In the year 2024, Modern Chinese Medicine Group had annual revenue of 214.07M CNY, down -37.78%. Modern Chinese Medicine Group had revenue of 137.44M in the half year ending December 31, 2024, a decrease of -32.49%.
Revenue
214.07M CNY
Revenue Growth
-37.78%
P/S Ratio
2.37
Revenue / Employee
1.13M CNY
Employees
190
Market Cap
540.00M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| Sino Biopharmaceutical | 30.72B |
| Akeso | 2.26B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |